PCN17 Chemotherapy Treatment and Impact of Second Line Chemotherapy on Overall Survival (OS) in Metastatic Castrate Resistant Prostate Cancer (CRPC) in Southeastern Oncology Community Practice
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1135
https://www.valueinhealthjournal.com/article/S1098-3015(12)01200-4/fulltext
Title :
PCN17 Chemotherapy Treatment and Impact of Second Line Chemotherapy on Overall Survival (OS) in Metastatic Castrate Resistant Prostate Cancer (CRPC) in Southeastern Oncology Community Practice
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01200-4&doi=10.1016/j.jval.2012.03.1135
First page :
A210
Section Title :
Cancer
Open access? :
No
Section Order :
656